文献速递创伤骨科

小鼠骨感染模型中急性与慢性骨折相关感染来源的金黄色葡萄球菌在细菌学和组织病理学上存在重要差异

Staphylococcus aureus From an Acute Fracture-related Infection Displays Important Bacteriological and Histopathologic Differences From a Chronic Equivalent in a Murine Bone Infection Model.
PubMed 文献 · Clin Orthop Relat Res · 2023-07-13

该研究在小鼠股骨骨折相关感染模型中比较了低毒力(Lo-SA5464)与高毒力(Hi-SA5458)金黄色葡萄球菌临床分离株的感染过程,评估体重变化、定量细菌学、免疫反应及影像和组织病理学。高毒力株感染表现为更高细菌负荷、更强全身播散和更明显的炎症反应,且骨愈合程度更低。

要点

  • 高毒力株Hi-SA5458感染小鼠在术后14天体重下降更明显,且软组织细菌负荷更高。
  • Hi-SA5458株感染小鼠器官播散比例更高(67% vs 14%),并伴随更强的促炎细胞因子反应。
  • 低毒力株Lo-SA5464感染小鼠在术后14天骨愈合程度更高,组织病理学评级更优。

核心结论

  • 在小鼠模型中,Hi-SA5458株感染以更高细菌负荷、更强全身播散及更强全身和局部炎症为特征,与人类宿主脓毒感染相似。
  • 研究结果强力支持致病菌毒力在骨折相关感染中起关键作用的观点。
  • 作者建议未来研究应在更多临床分离株和患者中从基因组和转录组层面表征金黄色葡萄球菌毒力,并通过体外和体内比较敲除株与野生株来确认发现并鉴定与毒力相关的基因组特征。

研究设计与样本

  • 研究使用25只(包括1只替换动物)雌性、骨骼成熟的C57Bl/6N近交系小鼠,年龄20至28周,行股骨截骨并以钛锁定钢板固定。
  • 通过向骨折间隙接种高毒力金黄色葡萄球菌EDCC 5458(Hi-SA5458)或低毒力金黄色葡萄球菌EDCC 5464(Lo-SA5464)建立骨折相关感染,每组12只随机分组动物。
  • 小鼠于术后4天和14天安乐死,每个时间点每组6只动物;评估包括体重变化的临床观察、定量细菌学、血清细胞因子水平、死后X线片定性分析和半定量组织病理学评估。

主要发现

  • 术后第4天,Hi-SA5458组与Lo-SA5464组体重变化无差异(均值-0.6±0.1克 vs -0.8±0.2克,均值差-0.2克[95%CI -0.8至0.5克];p=0.43);第14天,Hi-SA5458组体重下降多于Lo-SA5464组(均值-1.55±0.2克 vs -0.8±0.3克;均值差0.7克[95%CI 0.2至1.3克];p=0.02)。
  • 术后4天,Hi-SA5458组软组织样本细菌负荷高于Lo-SA5464组(中位数6.8×10^7 CFU/g,范围2.2×10^7至2.1×10^9 CFU/g vs 中位数6.0×10^6 CFU/g,范围1.8×10^5至1.3×10^8 CFU/g;中位数差6.2×10^7 CFU/g;p=0.03)。
  • 两个时间点,Hi-SA5458组器官细菌播散比例高于Lo-SA5464组(67%[24/36器官] vs 14%[5/36器官];OR 12.0[95%CI 3.7至36];p<0.001)。
  • 第14天,Hi-SA5458组血清细胞因子水平高于Lo-SA5464组:白介素-1β均值9.0±2.2 pg/mL vs 5.3±1.5 pg/mL(均值差3.6 pg/mL[95%CI 2.0至5.2 pg/mL];p<0.001);白介素-6均值458.6±370.7 pg/mL vs 201.0±89.6 pg/mL(均值差257.6 pg/mL[95%CI 68.7至446.5 pg/mL];p=0.006);白介素-10均值15.9±3.5 pg/mL vs 9.9±1.0 pg/mL(均值差6.0 pg/mL[95%CI 3.2至8.7 pg/mL];p<0.001);干扰素-γ均值2.7±1.9 pg/mL vs 0.8±0.3 pg/mL(均值差1.8 pg/mL[95%CI 0.5至3.1 pg/mL];p=0.002)。
  • 第4天半定量组织病理学评估显示Hi-SA5458组粒细胞浸润分级高于Lo-SA5464组(均值分级2.5±1.0 vs 1.8±1.4;均值差0.7[95%CI 0.001至1.4];p=0.0498);第14天Lo-SA5464组骨折部位骨愈合程度高于Hi-SA5458组(均值分级0.2±0.4 vs 1.8±1.2;均值差-1.6[95%CI -2.8至-0.5];p=0.008)。

临床怎么用

  • 作者认为,金黄色葡萄球菌毒力谱未来可能有助于指导治疗决策。
  • 作者提出,一旦鉴定出特定毒力靶点,针对高毒力株骨折相关感染的一种方法可能是开发抗毒力药物,尤其用于治疗或预防脓毒播散。
  • 作者提出,对于低毒力骨折相关感染,由于生长缓慢和持续存在能力,延长抗菌治疗或更换留置植入物可能有益。

局限性

  • 作者指出需未来研究在更多临床分离株和患者中从基因组和转录组层面表征金黄色葡萄球菌毒力以确认观察结果。
  • 作者指出通过体外和体内比较敲除株与野生株(包括所研究的金黄色葡萄球菌株)可确认发现并鉴定与骨折相关感染中毒力相关的基因组特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staphylococcus aureus is the leading pathogen in fracture-related infection. Previous in vitro experiments, in vivo testing in wax moth larvae, and genomic analysis of clinical S. aureu s isolates from fracture-related infection identified low-virulence (Lo-SA5464) and high-virulence (Hi-SA5458) strains. These findings correlated with acute fracture-related infection induced by Hi-SA5458, whereas Lo-SA5464 caused a chronic fracture-related infection in its human host. However, it remains unclear whether and to what extent the causative pathogen is attributable to these disparities in fracture-related infections. QUESTION/PURPOSE: Are there differences in the course of infection when comparing these two different clinical isolates in a murine fracture-related infection model, as measured by (1) clinical observations of weight loss, (2) quantitative bacteriology, (3) immune response, and (4) radiographic and histopathologic morphology? METHODS: Twenty-five (including one replacement animal) female (no sex-specific influences expected), skeletally mature C57Bl/6N inbred mice between 20 and 28 weeks old underwent femoral osteotomy stabilized by titanium locking plates. Fracture-related infection was established by inoculation of high-virulence S. aureus EDCC 5458 (Hi-SA5458) or low-virulence S. aureus EDCC 5464 (Lo-SA5464) in the fracture gap. Each of these groups consisted of 12 randomly assigned animals. Mice were euthanized 4 and 14 days postsurgery, resulting in six animals per group and timepoint. The severity and progression of infection were assessed in terms of clinical observation of weight loss, quantitative bacteriology, quantitative serum cytokine levels, qualitative analysis of postmortem radiographs, and semiquantitative histopathologic evaluation. RESULTS: For clinical observations of weight change, no differences were seen at Day 4 between Hi-SA5458- and Lo-SA5464-infected animals (mean -0.6 ± 0.1 grams versus -0.8 ± 0.2 grams, mean difference -0.2 grams [95% CI -0.8 to 0.5 grams]; p =0.43), while at 14 days, the Hi-SA5458 group lost more weight than the Lo-SA5464 group (mean -1.55 ± 0.2 grams versus -0.8 ± 0.3 grams; mean difference 0.7 grams [95% CI 0.2 to 1.3 grams]; p = 0.02). Quantitative bacteriological results 4 days postoperatively revealed a higher bacterial load in soft tissue samples in Hi-SA5458-infected animals than in the Lo-SA5464-infected cohort (median 6.8 x 10 7 colony-forming units [CFU]/g, range 2.2 x 10 7 to 2.1 x 10 9 CFU/g versus median 6.0 x 10 6 CFU/g, range 1.8 x 10 5 to 1.3 x 10 8 CFU/g; difference of medians 6.2 x 10 7 CFU/g; p = 0.03). At both timepoints, mice infected with the Hi-SA5458 strain also displayed higher proportions of bacterial dissemination into organs than Lo-SA5464-infected animals (67% [24 of 36 organs] versus 14% [five of 36 organs]; OR 12.0 [95% CI 3.7 to 36]; p < 0.001). This was accompanied by a pronounced proinflammatory response on Day 14, indicated by increased serum cytokine levels of interleukin-1β (mean 9.0 ± 2.2 pg/mL versus 5.3 ± 1.5 pg/mL; mean difference 3.6 pg/mL [95% CI 2.0 to 5.2 pg/mL]; p < 0.001), IL-6 (mean 458.6 ± 370.7 pg/mL versus 201.0 ±89.6 pg/mL; mean difference 257.6 pg/mL [95% CI 68.7 to 446.5 pg/mL]; p = 0.006), IL-10 (mean 15.9 ± 3.5 pg/mL versus 9.9 ± 1.0 pg/mL; mean difference 6.0 pg/mL [95% CI 3.2 to 8.7 pg/mL]; p < 0.001), and interferon-γ (mean 2.7 ± 1.9 pg/mL versus 0.8 ± 0.3 pg/mL; mean difference 1.8 pg/mL [95% CI 0.5 to 3.1 pg/mL]; p = 0.002) in Hi-SA5458-infected compared with Lo-SA5464-infected animals. The semiquantitative histopathologic assessment on Day 4 revealed higher grades of granulocyte infiltration in Hi-SA5458-infected animals (mean grade 2.5 ± 1.0) than in Lo-SA5464-infected animals (mean grade 1.8 ± 1.4; mean difference 0.7 [95% CI 0.001 to 1.4]; p = 0.0498). On Day 14, bone healing at the fracture site was present to a higher extent in Lo-SA5464-infected animals than in Hi-SA5458-infected animals (mean grade 0.2 ± 0.4 versus 1.8 ± 1.2; mean difference -1.6 [95% CI -2.8 to -0.5]; p = 0.008). CONCLUSION: Similar to septic infection in a human host, infection with Hi-SA5458 in this murine model was characterized by a higher bacterial load, more-pronounced systemic dissemination, and stronger systemic and local inflammation. Thus, there is strong support for the idea that pathogenic virulence plays a crucial role in fracture-related infections. To confirm our observations, future studies should focus on characterizing S. aureus virulence at the genomic and transcriptomic levels in more clinical isolates and patients. Comparing knockout and wildtype strains in vitro and in vivo, including the S. aureus strains studied, could confirm our findings and identify the genomic features responsible for S. aureus virulence in fracture-related infections. CLINICAL RELEVANCE: For translational use, virulence profiles of S. aureus may be useful in guiding treatment decisions in the future. Once specific virulence targets are identified, one approach to fracture-related infections with high-virulence strains might be the development of antivirulence agents, particularly to treat or prevent septic dissemination. For fracture-related infections with low virulence, prolonged antimicrobial therapy or exchange of an indwelling implant might be beneficial owing to slower growth and persistence capacity.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Baertl S, Gens L, Nehrbass D, et al. Staphylococcus aureus From an Acute Fracture-related Infection Displays Important Bacteriological and Histopathologic Differences From a Chronic Equivalent in a Murine Bone Infection Model. Clin Orthop Relat Res. 2023. PMID: 37439643. doi:10.1097/CORR.0000000000002753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。